Aspen Global Incorporated, often referred to as Aspen Global, is a leading player in the pharmaceutical and healthcare industry, headquartered in Mauritius (MU). Founded in 2007, the company has established a strong presence across various operational regions, including Africa and the Middle East. Aspen Global is renowned for its extensive portfolio of high-quality generic and branded medicines, particularly in the fields of anaesthetics, oncology, and critical care. Their commitment to innovation and quality sets them apart in a competitive market, enabling them to meet diverse healthcare needs effectively. With a focus on sustainability and access to essential medicines, Aspen Global has achieved significant milestones, positioning itself as a trusted partner in healthcare. The company continues to expand its reach, contributing to improved health outcomes worldwide.
How does Aspen Global Incorporated's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Aspen Global Incorporated's score of 44 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Aspen Global Incorporated, headquartered in Mauritius (MU), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Aspen Pharmacare Holdings Limited, which may influence its climate commitments and emissions reporting. As of now, Aspen Global has not outlined any specific reduction targets or initiatives related to carbon emissions. The absence of documented reduction initiatives or commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the lack of direct emissions data, it is important to note that any climate-related initiatives or targets may be inherited from its parent company, Aspen Pharmacare Holdings Limited. This relationship could potentially provide a framework for future climate commitments, although specific details are not currently available. In summary, while Aspen Global Incorporated is part of a larger corporate family that may have climate initiatives, it has not yet established its own emissions data or reduction targets.
Access structured emissions data, company-specific emission factors, and source documents
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 13,149,000 | 00,000,000 | - | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 34,934,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 00,000,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Fuel and Energy Related Activities" being the largest emissions source at 74% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aspen Global Incorporated has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.